Retatrutide
€75.00
-
Worldwide Delivery
-
Payment
Description
Retatrutide
Retatrutide, also called LY-3437943, is a 39 amino acid peptide acting on GLP-1, GIP and glucagon receptors. Its resistance to DPP-4 cleavage is described in relation to prolonged activity.
Product specifications
Three metabolic receptor pathways
The description links GLP-1 and GIP activity with appetite and insulin response, while the glucagon receptor pathway contributes to energy expenditure. It identifies Retatrutide as a compound studied in obesity and type 2 diabetes contexts.
- Appetite control effects
- Glycemic response support
- Glucagon related energy expenditure
- Prolonged activity across three receptor pathways
Usage and administration
The described profile includes subcutaneous administration once weekly, with gradual escalation from a low amount to manage nausea and gastrointestinal effects. It provides no numerical product strength or administration range.
Related products and comparisons
Semaglutide and Tirzepatide are the single- and dual agonist compounds named when comparing metabolic receptor profiles.
Health and usage information
This page provides educational information about the product to help you make informed choices. It does not replace medical advice. If you have a health condition or questions about dosage, consult a sports medicine doctor or another healthcare professional.
Specification
Overview
Customer Reviews
You may also like
Reviews
There are no reviews yet.